These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 9636213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, Murphy DL, Uhl GR.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):5300-5. PubMed ID: 11320258
    [Abstract] [Full Text] [Related]

  • 3. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
    Hall FS, Li XF, Sora I, Xu F, Caron M, Lesch KP, Murphy DL, Uhl GR.
    Neuroscience; 2002 Apr 24; 115(1):153-61. PubMed ID: 12401330
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms underlying the rewarding effects of cocaine.
    Hall FS, Sora I, Drgonova J, Li XF, Goeb M, Uhl GR.
    Ann N Y Acad Sci; 2004 Oct 24; 1025():47-56. PubMed ID: 15542699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice.
    Stewart A, Davis GL, Gresch PJ, Katamish RM, Peart R, Rabil MJ, Gowrishankar R, Carroll FI, Hahn MK, Blakely RD.
    Neuropsychopharmacology; 2019 Apr 24; 44(5):994-1006. PubMed ID: 30578419
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate.
    Meltzer PC, Wang P, Blundell P, Madras BK.
    J Med Chem; 2003 Apr 10; 46(8):1538-45. PubMed ID: 12672255
    [Abstract] [Full Text] [Related]

  • 16. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.
    Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S, Quan N, Stephens RL, Hill ER, Nottoli T, Han DD, Gu HH.
    Proc Natl Acad Sci U S A; 2006 Jun 13; 103(24):9333-8. PubMed ID: 16754872
    [Abstract] [Full Text] [Related]

  • 17. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.
    Gatley SJ, Volkow ND, Gifford AN, Fowler JS, Dewey SL, Ding YS, Logan J.
    Psychopharmacology (Berl); 1999 Sep 01; 146(1):93-100. PubMed ID: 10485970
    [Abstract] [Full Text] [Related]

  • 18. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
    Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G.
    J Neurosci; 2001 May 01; 21(9):RC141: 1-4. PubMed ID: 11312315
    [Abstract] [Full Text] [Related]

  • 19. Increased rewarding properties of morphine in dopamine-transporter knockout mice.
    Spielewoy C, Gonon F, Roubert C, Fauchey V, Jaber M, Caron MG, Roques BP, Hamon M, Betancur C, Maldonado R, Giros B.
    Eur J Neurosci; 2000 May 01; 12(5):1827-37. PubMed ID: 10792459
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.